Praxis Precision Medicines, Inc. closed fiscal year 2025 with $937.9M in total assets, $59.8M in total liabilities and $878.1M in shareholder equity. This represents an increase of 94.1% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Praxis Precision Medicines, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PRAX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY21DEF 14A | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $937.9M+94.1% | $483.1M+449.3% | $87.9M-23.6% | $115.1M-60.7% | $292.7M-3.4% | $303.2M+535.7% | $47.7M |
| Total Liabilities | $59.8M+58.7% | $37.7M+106.0% | $18.3M-53.2% | $39.0M-6.9% | $41.9M+166.8% | $15.7M-87.8% | $128.7M |
| Total Equity | $878.1M+97.1% | $445.4M+539.4% | $69.7M-8.5% | $76.1M-69.7% | $250.8M-12.7% | $287.5M+454.9% | -$81.0M |
PRAX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B+207.0% | $1.5B+205.0% | $937.9M+94.1% | $396.4M-4.8% | $452.8M+2.7% | $478.7M+91.2% | $483.1M+449.3% | $416.3M+290.0% | $441.1M+230.4% | $250.4M+154.5% | $87.9M-23.6% | $106.7M-22.0% |
| Total Liabilities | $49.1M+0.9% | $50.2M+27.1% | $59.8M+58.7% | $52.9M+57.4% | $48.6M+121.3% | $39.5M+90.7% | $37.7M+106.0% | $33.6M+68.2% | $22.0M-21.2% | $20.7M-38.9% | $18.3M-53.2% | $20.0M-37.1% |
| Total Equity | $1.3B+231.8% | $1.4B+221.0% | $878.1M+97.1% | $343.5M-10.2% | $404.2M-3.5% | $439.2M+91.2% | $445.4M+539.4% | $382.7M+341.1% | $419.1M+296.8% | $229.7M+256.3% | $69.7M-8.5% | $86.8M-17.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Praxis Precision Medicines, Inc. financials
Frequently Asked Questions
What was Praxis Precision Medicines, Inc.'s total assets in fiscal year 2025?
Praxis Precision Medicines, Inc. closed fiscal year 2025 with $937.9M in total assets, $59.8M in total liabilities and $878.1M in shareholder equity.
How fast is Praxis Precision Medicines, Inc.'s total assets growing?
Praxis Precision Medicines, Inc. (PRAX) total assets rose by 94.1% year over year, from $483.1M to $937.9M in fiscal year 2025.
How has Praxis Precision Medicines, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, Praxis Precision Medicines, Inc. (PRAX) total assets went from $47.7M in fiscal year 2019 to $937.9M in fiscal year 2025.
What was Praxis Precision Medicines, Inc.'s total assets in the most recent quarter?
Praxis Precision Medicines, Inc. (PRAX) reported $1.4B in total assets in Q2 2026. This represents an increase of 207.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Praxis Precision Medicines, Inc. (PRAX) reported on that line in every period on record.